Endothelium: Interface between coagulation and inflammation

Critical Care Medicine

Volumn 30, Issue 5 SUPPL., 2002, Pages

  Levi, Marcel ^a   Ten Cate, Hugo ^a   Van der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antithrombin; Coagulation; Cytokine; Protein C; Sepsis; Thrombin; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

CYTOKINE; PROTEIN C; THROMBOPLASTIN;

BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CONFERENCE PAPER; ENDOTHELIUM; FIBRINOLYSIS; HEMOSTASIS; INFECTION; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; THROMBOGENESIS;

EID: 0036255897     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200205001-00008     Document Type: Conference Paper

References (52)

1. Disseminated intravascular coagulation
2. Disseminated intravascular coagulation: State of the art
3. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis
4. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia
5. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome
6. Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis
7. The role of the tissue factor pathway in initiation of coagulation
8. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor
9. Cell biology of tissue factor, the principal initiator of blood coagulation
10. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation
11. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock
12. Tissue factor expression by endothelial cells in sickle cell anemia
13. Vascular-bed-specific hemostasis and hypercoagulable states
14. Induction of tissue factor expression in whole blood: Lack of evidence for the presence of tissue factor expression on granulocytes
15. Virus infection of endothelial cells
16. Dengue virus and endothelial cell: A related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever
17. The procoagulant response of cytomegalovirus infected endothelial cells
18. Viral activation of the coagulation cascade: Molecular interactions at the surface of infected endothelial cells
19. Glycosaminoglycans and the regulation of blood coagulation
20. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation
21. The roles of protein C and thrombomodulin in the regulation of blood coagulation
22. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor
23. Human protein C receptor is present primarily on endothelium of large blood vessels: Implications for the control of the protein C pathway
24. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
25. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture
26. Dysfunction of endothelial protein C activation in severe meningococcal sepsis
27. Role of free protein S and C4b binding protein in regulating the coagulant response to Escherichia coli
28. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
29. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications
30. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
31. Efficacy and safety of recombinant human activated protein C for severe sepsis
32. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples
33. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiologic role for EPI as a natural anticoagulant
34. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
35. Tissue factor pathway inhibitor (TFPI) dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
36. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: Effect of interventions in the cytokine and coagulation cascades
37. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock
38. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo: Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta
39. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator
40. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
41. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees
42. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia
43. Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa
44. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
45. Hemostatic factors and inflammatory disease
46. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation
47. The proinflammatory cytokine response to coagulation and endotoxin in whole blood
48. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
49. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages
50. Activation of coagulation by administration of recombinant factor VIIa elicits interleukin-6 and interleukin-8 release in healthy human subjects
51. Does inflammation contribute to thrombotic events?
52. The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy